SLN:NASDAQ
Silence Therapeutics PLC - ADR
၁၉.၈၀ US$
arrow_upward
+၀.၁၀%(+၀.၀၂၀) 1D
၁၉.၈၀ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: နို ၄, GMT-၅ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SLN...
Open
၁၉.၇၈ US$
High
၁၉.၈၀ US$
Low
၁၉.၇၅ US$
Mkt. cap
၁၂၁.၇၉ ဋေ
Avg. vol.
၄.၂၅ သန်း
Volume
၁.၀၂ သန်း
52-wk high
၁၉.၈၆ US$
52-wk low
၄.၁၉ US$
EPS
-၁.၄၅ US$
Beta
၁.၃၄
Shares outstanding
၆.၀၂ ကုဋေ
No. of employees
၈၈
Open
၁၉.၇၈ US$
High
၁၉.၈၀ US$
Low
၁၉.၇၅ US$
Mkt. cap
၁၂၁.၇၉ ဋေ
Avg. vol.
၄.၂၅ သန်း
Volume
၁.၀၂ သန်း
52-wk high
၁၉.၈၆ US$
52-wk low
၄.၁၉ US$
EPS
-၁.၄၅ US$
Beta
၁.၃၄
Shares outstanding
၆.၀၂ ကုဋေ
No. of employees
၈၈
News stories
From web sources and news partners
Investing.com
·
ပြီးခဲ့သည့် ၁၄ နာရီ
Silence Therapeutics data accepted for ASH presentation
Profile
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London. Wikipedia
About Silence Therapeutics PLC - ADR